Skip to main content
Menu
US

IVISense Vascular NP 680 Fluorescent Nanoparticles (AngioSPARK)

IVISense™ Vascular NP (AngioSPARK®) is a fluorescent nanoparticle probe with a long pharmacokinetic profile for imaging vascularity, vascular leak, blood-brain-barrier compromise, and vascular cell fluid-phase pinocytosis.

Revvity's IVISense Vascular NP fluorescent nanoparticle probes are available in 680 and 750 nm wavelengths ideal for multiplexing with other probes.

For research use only. Not for use in diagnostic procedures.

Feature Specification
Unit Size 1 Vial (5 doses)

IVISense™ Vascular NP (AngioSPARK®) is a fluorescent nanoparticle probe with a long pharmacokinetic profile for imaging vascularity, vascular leak, blood-brain-barrier compromise, and vascular cell fluid-phase pinocytosis.

Revvity's IVISense Vascular NP fluorescent nanoparticle probes are available in 680 and 750 nm wavelengths ideal for multiplexing with other probes.

For research use only. Not for use in diagnostic procedures.

Product Variants
Wave Length: 680 nm
Part #:
NEV10149
List Price
USD 772.40
Wave Length: 750 nm
Part #:
NEV10150
List Price
USD 773.43

Overview

IVISense Vascular NP 680 is a highly fluorescent near-infrared nanoparticle probe specifically designed for in vivo imaging. IVISense Vascular NP 680 contains an iron oxide core that is coated to specifically produce a functionalized biocompatible probe comprised of a pegylated fluorescent nanoparticle that remains localized in the vasculature for extended periods of time and enables imaging of blood vessels, angiogenesis, blood-brain-barrier compromise, and vascular cell fluid-phase pinocytotic function. IVISense Vascular NP 680 fluorescent nanoparticle probe can also be used at later time points (>12 hours) to image vascular leak in tissue site of inflammation and cancer. IVISense Vascular NP 680 can be imaged within the interstitium for up to 24 hours post tail vein injection.

Benefits of IVISense Vascular NP fluorescent nanoparticles

  • Highly fluorescent near infrared nanoparticles specifically designed for in vivo vascular imaging.
    • Contain an iron oxide core that is coated to specifically produce a functionalized biocompatible product.
    • Pegylation facilitates extended blood half-life to enable imaging of blood vessels and angiogenesis.
  • Imaging of vascularity, perfusion, and vascular permeability. Long pharmacokinetic profile.
  • Long-term tissue accumulation in chronic inflammation and cancer/angiogenesis studies.
  • Vascularity in cancer and inflammation by noninvasive and intravital microscopy.
  • Assessment of CNS blood-brain-barrier compromise.
  • in vivo assessment of vascular fluid-phase pinocytosis in atherosclerosis
  • Can also be used at later time points (>12 hours) to image vascular leak in tissue site of inflammation and cancer.
  • Can be imaged within the interstitium for up to 24 hours post tail vein injection.

Specifications

Application
In vivo imaging
Brand
IVISense
Fluorescent Agent Type
Vascular
Imaging Modality
Fluorescence
Shipping Conditions
Shipped Ambient
Therapeutic Area
Angiogenesis
Arthritis
Atherosclerosis
Inflammation
Oncology/Cancer
Vascular disease
Unit Size
1 Vial (5 doses)
Wave Length
680 nm

Resources

Are you looking for resources, click on the resource type to explore further.

1-2 of 2 Resources
Application Note Icon
Application Note
Comparison of vascular fluorescent imaging agents in oncology and inflammation research

This app not highlights comparing IVISense Edema, IVISense Vascular, and IVISense Vascular NP NIR fluorescent probes to detect...

Application Note Icon
Application Note
Vascular imaging probes for oncology and inflammation

Optical-based in vivo imaging of vascular changes and vascular leak is an emerging modality for studying altered physiology in a...

SDS, COAs, Manuals and more

Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.

Safety data sheet
+ Show more
Technical data sheet
  • Lot number
    ANY
    Lot date
    September 6, 2023
+ Show more
Scroll Icon